377 related articles for article (PubMed ID: 30913985)
1. Process optimization and protein engineering mitigated manufacturing challenges of a monoclonal antibody with liquid-liquid phase separation issue by disrupting inter-molecule electrostatic interactions.
Du Q; Damschroder M; Pabst TM; Hunter AK; Wang WK; Luo H
MAbs; 2019; 11(4):789-802. PubMed ID: 30913985
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Antibody Engineering To Improve Viscosity and Phase Separation Guided by Crystal Structure.
Chow CK; Allan BW; Chai Q; Atwell S; Lu J
Mol Pharm; 2016 Mar; 13(3):915-23. PubMed ID: 26849155
[TBL] [Abstract][Full Text] [Related]
3. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
[TBL] [Abstract][Full Text] [Related]
4. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
[TBL] [Abstract][Full Text] [Related]
5. Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering.
Geoghegan JC; Fleming R; Damschroder M; Bishop SM; Sathish HA; Esfandiary R
MAbs; 2016 Jul; 8(5):941-50. PubMed ID: 27050875
[TBL] [Abstract][Full Text] [Related]
6. Adenosine Triphosphate-Induced Rapid Liquid-Liquid Phase Separation of a Model IgG1 mAb.
Tian Z; Qian F
Mol Pharm; 2021 Jan; 18(1):267-274. PubMed ID: 33307701
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives.
Wu G; Wang S; Tian Z; Zhang N; Sheng H; Dai W; Qian F
Eur J Pharm Biopharm; 2017 Nov; 120():1-8. PubMed ID: 28754261
[TBL] [Abstract][Full Text] [Related]
8. Liquid-liquid phase separation causes high turbidity and pressure during low pH elution process in Protein A chromatography.
Luo H; Lee N; Wang X; Li Y; Schmelzer A; Hunter AK; Pabst T; Wang WK
J Chromatogr A; 2017 Mar; 1488():57-67. PubMed ID: 28159365
[TBL] [Abstract][Full Text] [Related]
9. Stability of a high-concentration monoclonal antibody solution produced by liquid-liquid phase separation.
Bramham JE; Davies SA; Podmore A; Golovanov AP
MAbs; 2021; 13(1):1940666. PubMed ID: 34225583
[TBL] [Abstract][Full Text] [Related]
10. Resolving Liquid-Liquid Phase Separation for a Peptide Fused Monoclonal Antibody by Formulation Optimization.
Qi W; Alekseychyk L; Nuanmanee N; Temel DB; Jann V; Treuheit M; Razinkov V
J Pharm Sci; 2021 Feb; 110(2):738-745. PubMed ID: 32961238
[TBL] [Abstract][Full Text] [Related]
11. Resolving self-association of a therapeutic antibody by formulation optimization and molecular approaches.
Casaz P; Boucher E; Wollacott R; Pierce BG; Rivera R; Sedic M; Ozturk S; Thomas WD; Wang Y
MAbs; 2014; 6(6):1533-9. PubMed ID: 25484044
[TBL] [Abstract][Full Text] [Related]
12. Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability.
Alam ME; Geng SB; Bender C; Ludwig SD; Linden L; Hoet R; Tessier PM
Mol Pharm; 2018 Jan; 15(1):150-163. PubMed ID: 29154550
[TBL] [Abstract][Full Text] [Related]
13. Highly viscous antibody solutions are a consequence of network formation caused by domain-domain electrostatic complementarities: insights from coarse-grained simulations.
Buck PM; Chaudhri A; Kumar S; Singh SK
Mol Pharm; 2015 Jan; 12(1):127-39. PubMed ID: 25383990
[TBL] [Abstract][Full Text] [Related]
14. Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions.
Lai PK; Ghag G; Yu Y; Juan V; Fayadat-Dilman L; Trout BL
MAbs; 2021; 13(1):1991256. PubMed ID: 34747330
[TBL] [Abstract][Full Text] [Related]
15. Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.
Arora J; Hu Y; Esfandiary R; Sathish HA; Bishop SM; Joshi SB; Middaugh CR; Volkin DB; Weis DD
MAbs; 2016; 8(8):1561-1574. PubMed ID: 27560842
[TBL] [Abstract][Full Text] [Related]
16. Phase separation of an IgG1 antibody solution under a low ionic strength condition.
Nishi H; Miyajima M; Nakagami H; Noda M; Uchiyama S; Fukui K
Pharm Res; 2010 Jul; 27(7):1348-60. PubMed ID: 20401522
[TBL] [Abstract][Full Text] [Related]
17. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
18. Liquid-liquid phase separation of a monoclonal antibody at low ionic strength: Influence of anion charge and concentration.
Reiche K; Hartl J; Blume A; Garidel P
Biophys Chem; 2017 Jan; 220():7-19. PubMed ID: 27838577
[TBL] [Abstract][Full Text] [Related]
19. Investigating Liquid-Liquid Phase Separation of a Monoclonal Antibody Using Solution-State NMR Spectroscopy: Effect of Arg·Glu and Arg·HCl.
Kheddo P; Bramham JE; Dearman RJ; Uddin S; van der Walle CF; Golovanov AP
Mol Pharm; 2017 Aug; 14(8):2852-2860. PubMed ID: 28614662
[TBL] [Abstract][Full Text] [Related]
20. Characterization and Modeling of Reversible Antibody Self-Association Provide Insights into Behavior, Prediction, and Correction.
Mieczkowski C; Cheng A; Fischmann T; Hsieh M; Baker J; Uchida M; Raghunathan G; Strickland C; Fayadat-Dilman L
Antibodies (Basel); 2021 Feb; 10(1):. PubMed ID: 33671864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
